BioXFEL - Resources: Peripheral Blood Biomarkers Associated With Toxicity and Treatment Characteristics After 131 I- Metaiodobenzylguanidine Therapy in Patients With Neuroblastoma: Citations

Support

Support Options

Knowledge Base

Find information on common issues.
Ask the Community

Ask questions and find answers from other users.
Wish List

Suggest a new site feature or improvement.
Support Tickets

Check on status of your tickets.

Submit a Support Ticket

Username: optional Name: required E-mail: required Please answer the question: required
Sharks live in... Please leave this field blank. required

Problem: required Attach a screenshot: optional (.jpg, .jpeg, .jpe, .bmp, .tif, .tiff, .png, .gif, .pdf, .zip, .mpg, .mpeg, .avi, .mov, .wmv, .asf, .asx, .ra, .rm, .txt, .rtf, .doc, .xsl, .html, .js, .wav, .mp3, .eps, .ppt, .pps, .swf, .tar, .tex, .gz)

0 Citation(s)

0 questions (Ask a question)

Peripheral Blood Biomarkers Associated With Toxicity and Treatment Characteristics After 131 I- Metaiodobenzylguanidine Therapy in Patients With Neuroblastoma

By Kevin Campbell, Erin E. Karski, Aleksandra Olow, David A. Edmondson, Ayano C. Kohlgruber, Matthew Coleman¹, Daphne A. Haas-Kogan, Katherine K. Matthay, Steven G. DuBois

1. Radiation Oncology, Cancer Center